225 related articles for article (PubMed ID: 19506017)
1. A functional connection between pRB and transforming growth factor beta in growth inhibition and mammary gland development.
Francis SM; Bergsied J; Isaac CE; Coschi CH; Martens AL; Hojilla CV; Chakrabarti S; Dimattia GE; Khoka R; Wang JY; Dick FA
Mol Cell Biol; 2009 Aug; 29(16):4455-66. PubMed ID: 19506017
[TBL] [Abstract][Full Text] [Related]
2. A context-specific role for retinoblastoma protein-dependent negative growth control in suppressing mammary tumorigenesis.
Francis SM; Chakrabarti S; Dick FA
PLoS One; 2011 Feb; 6(2):e16434. PubMed ID: 21364977
[TBL] [Abstract][Full Text] [Related]
3. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.
Gorska AE; Jensen RA; Shyr Y; Aakre ME; Bhowmick NA; Moses HL
Am J Pathol; 2003 Oct; 163(4):1539-49. PubMed ID: 14507660
[TBL] [Abstract][Full Text] [Related]
4. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.
Gorska AE; Joseph H; Derynck R; Moses HL; Serra R
Cell Growth Differ; 1998 Mar; 9(3):229-38. PubMed ID: 9543389
[TBL] [Abstract][Full Text] [Related]
5. Understanding mammary gland development through the imbalanced expression of growth regulators.
Robinson GW; Smith GH; Gallahan D; Zimmer A; Furth PA; Hennighausen L
Dev Dyn; 1996 Jun; 206(2):159-68. PubMed ID: 8725283
[TBL] [Abstract][Full Text] [Related]
6. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
7. Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation.
Ewan KB; Shyamala G; Ravani SA; Tang Y; Akhurst R; Wakefield L; Barcellos-Hoff MH
Am J Pathol; 2002 Jun; 160(6):2081-93. PubMed ID: 12057913
[TBL] [Abstract][Full Text] [Related]
8. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
Robinson GW; Wagner KU; Hennighausen L
Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta regulator SnoN modulates mammary gland branching morphogenesis, postlactational involution, and mammary tumorigenesis.
Jahchan NS; You YH; Muller WJ; Luo K
Cancer Res; 2010 May; 70(10):4204-13. PubMed ID: 20460516
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells.
Smith GH; Sharp R; Kordon EC; Jhappan C; Merlino G
Am J Pathol; 1995 Oct; 147(4):1081-96. PubMed ID: 7573353
[TBL] [Abstract][Full Text] [Related]
11. Conditional overexpression of liver receptor homolog-1 in female mouse mammary epithelium results in altered mammary morphogenesis via the induction of TGF-β.
Lazarus KA; Brown KA; Young MJ; Zhao Z; Coulson RS; Chand AL; Clyne CD
Endocrinology; 2014 May; 155(5):1606-17. PubMed ID: 24564400
[TBL] [Abstract][Full Text] [Related]
12. Ectopic TGF beta 1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population.
Kordon EC; McKnight RA; Jhappan C; Hennighausen L; Merlino G; Smith GH
Dev Biol; 1995 Mar; 168(1):47-61. PubMed ID: 7883078
[TBL] [Abstract][Full Text] [Related]
13. The V-ATPase a2 isoform controls mammary gland development through Notch and TGF-β signaling.
Pamarthy S; Mao L; Katara GK; Fleetwood S; Kulshreshta A; Gilman-Sachs A; Beaman KD
Cell Death Dis; 2016 Nov; 7(11):e2443. PubMed ID: 27809299
[TBL] [Abstract][Full Text] [Related]
14. Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway.
Bailey JP; Nieport KM; Herbst MP; Srivastava S; Serra RA; Horseman ND
Mol Endocrinol; 2004 May; 18(5):1171-84. PubMed ID: 14963111
[TBL] [Abstract][Full Text] [Related]
15. Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-beta.
Yang YA; Tang B; Robinson G; Hennighausen L; Brodie SG; Deng CX; Wakefield LM
Cell Growth Differ; 2002 Mar; 13(3):123-30. PubMed ID: 11959813
[TBL] [Abstract][Full Text] [Related]
16. Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.
Roarty K; Baxley SE; Crowley MR; Frost AR; Serra R
Breast Cancer Res; 2009; 11(2):R19. PubMed ID: 19344510
[TBL] [Abstract][Full Text] [Related]
17. Activated Abl kinase inhibits oncogenic transforming growth factor-beta signaling and tumorigenesis in mammary tumors.
Allington TM; Galliher-Beckley AJ; Schiemann WP
FASEB J; 2009 Dec; 23(12):4231-43. PubMed ID: 19690215
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta promotes cell death and suppresses lactation during the second stage of mammary involution.
Bierie B; Gorska AE; Stover DG; Moses HL
J Cell Physiol; 2009 Apr; 219(1):57-68. PubMed ID: 19086032
[TBL] [Abstract][Full Text] [Related]
19. The transforming growth factors beta in development and functional differentiation of the mouse mammary gland.
Daniel CW; Robinson S; Silberstein GB
Adv Exp Med Biol; 2001; 501():61-70. PubMed ID: 11787732
[TBL] [Abstract][Full Text] [Related]
20. Progesterone receptor isoforms and proliferation in the rat mammary gland during development.
Kariagina A; Aupperlee MD; Haslam SZ
Endocrinology; 2007 Jun; 148(6):2723-36. PubMed ID: 17332059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
